article thumbnail

STAT+: Belgian anti-trust authorities probe Roche for allegedly delaying biosimilars of two cancer meds

STAT

In a brief statement , the Belgian Competition Authority alleged that Roche offered financial incentives to hospitals between 2017 and 2020 to deter them from considering competitive bids from other pharmaceutical companies that could supply similar medicines.

article thumbnail

Scientists want to put carbon footprints on drugs. But it’s hard to get accurate numbers

STAT

Anyone picking up a prescription from their pharmacy is used to the reams of paper that typically accompany it: information on safety, storing, and how to use the drug. What if that information also included your medicine’s carbon footprint?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Opinion: STAT+: How to keep the BIOSECURE Act from hobbling U.S. biotech and pharma

STAT

The BIOSECURE Act would prohibit many biotech and pharmaceutical companies from conducting certain research and development activities, including the manufacturing of drugs through named Chinese companies. Protecting that information and being able to make our own medicines should be a national priority.

article thumbnail

The Comprehensive Science and Art of Pharmaceutical Drug Naming

Drug Patent Watch

Pharmaceutical drug names are more than just a label - they're a carefully crafted code that conveys essential information about the medication. But what drives this complex system, and how do pharmaceutical companies ensure that their drug names meet the strict guidelines set by regulatory agencies?

article thumbnail

STAT+: Biden administration makes opening offers in Medicare drug price negotiations

STAT

WASHINGTON  — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.

article thumbnail

STAT+: FDA scolds Merz over ‘misleading’ Instagram posts featuring interior designer Nate Berkus

STAT

The Food and Drug Administration has scolded Merz Pharmaceutical for making misleading claims on Instagram about the safety and effectiveness of an injectable treatment for smoothing facial lines, the fifth time this year the agency has taken a pharmaceutical company to task for its marketing.

article thumbnail

Opinion: A dangerous loophole for drug ads needs to be closed

STAT

A loophole in prescription drug regulation exposes American consumers to false and misleading claims of drug ads via on-line businesses promoting potent drugs without accurate information about their risks and benefits. Many countries prohibit direct-to-consumer advertising of prescription drugs.